Literature DB >> 24785894

Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors.

Ken Ikeda1, Masaru Yanagihashi, Masahiro Sawada, Sayori Hanashiro, Kiyokazu Kawabe, Yasuo Iwasaki.   

Abstract

We herein report an 81-year-old woman with Alzheimer's disease (AD) in who donepezil, a cholinesterase inhibitor (ChEI), caused cervical dystonia. The patient had a two-year history of progressive memory disturbance fulfilling the NINCDS-ADRDA criteria for probable AD. Mini-Mental State Examination score was 19/30. The remaining examination was normal. After a single administration of donepezil (5 mg/day) for 10 months, she complained of dropped head. Neurological examination and electrophysiological studies supported a diagnosis of cervical dystonia. Antecollis disappeared completely at 6 weeks after cessation of donepezil. Dystonic posture can occur at various timings of ChEI use. Physicians should pay more attention to rapidly progressive cervical dystonia in ChEI-treated AD patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24785894     DOI: 10.2169/internalmedicine.53.1857

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Butanol Extract of Tinospora cordifolia Ameliorates Cognitive Deficits Associated with Glutamate-Induced Excitotoxicity: A Mechanistic Study Using Hippocampal Neurons.

Authors:  Anuradha Sharma; Shikha Kalotra; Payal Bajaj; Harpal Singh; Gurcharan Kaur
Journal:  Neuromolecular Med       Date:  2019-10-12       Impact factor: 3.843

2.  Pedunculopontine Nucleus Cholinergic Deficiency in Cervical Dystonia.

Authors:  Karin Mente; Nancy A Edwards; Demelio Urbano; Abhik Ray-Chaudhury; Diego Iacono; Ana Tereza Di Lorenzo Alho; Eduardo Joaquim Lopes Alho; Edson Amaro; Silvina G Horovitz; Mark Hallett
Journal:  Mov Disord       Date:  2018-03-06       Impact factor: 10.338

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.